Latest Datamonitor Stories

2008-06-17 12:00:09

Reportlinker.com announces that a new market research report related to the Consumer trends industry is available in its catalogue.

2007-11-21 06:00:15

Research and Markets (http://www.researchandmarkets.com/reports/c74978) has announced the addition of Datamonitor's new report: The HP ALM Radars (Vendor Focus) to their offering. Introduction This brief analyses the strengths and weaknesses of HP's Application Lifecycle Management offering.

2007-10-25 12:00:22

Given that BioMarin Pharmaceuticals's Kuvan is potentially the only treatment for the rare genetic metabolic disorder phenylketonuria, Datamonitor believes that Wall Street may be underestimating Kuvan's market potential.

2007-01-26 09:00:44

Salix Pharmaceuticals' antibiotic Xifaxan was approved by the FDA for the treatment of traveler's diarrhea (TD) in 2004. However, the majority of Xifaxan use is accounted for by off-label indications, growth in which is essential to its revenue potential.

2006-11-16 15:01:30

Allergan's memantine could offer a novel mechanism to slow glaucoma progression if the current phase III trial shows positive data.

2006-01-16 19:08:50

By Ben Hirschler, European Pharmaceuticals Correspondent LONDON (Reuters) - The first copycat versions of biotech medicines could be approved in Europe later this year, while the United States is unlikely to get them before 2009, according to a report on Tuesday.

Word of the Day
  • An uxorious, effeminate, or spiritless man.
  • A timorous, cowardly fellow.
Probably a blend of meek and cock, or from meek +‎ -ock (“diminutive suffix”).